Markus M. Lerch

Markus M. Lerch

Ludwig Maximilians Universität München - Munich / Germany
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1756956
Ludwig Maximilian University of Munich
person_outline Markus M. Lerch's MOST POPULAR ARTICLES
1-) Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. RI Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B ... N Engl J Med. 396 (14), 1317-26, 2013 3957*2013
2-) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised … JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ... The Lancet 389 (10073), 1011-1024, 2017 16342017
3-) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology T Shimosegawa, ST Chari, L Frulloni, T Kamisawa, S Kawa, ... Pancreas 40 (3), 352-358, 2011 15452011
4-) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trialJP Neoptolemos, DD Stocken, C Bassi, P Ghaneh, D Cunningham, ...Jama 304 (10), 1073-1081, 201016932010
5-) IAP guidelines for the surgical management of acute pancreatitisW Uhl, A Warshaw, C Imrie, C Bassi, CJ McKay, PG Lankisch, R Carter, ...Pancreatology 2 (6), 565-573, 200214902002